BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9649359)

  • 1. Determination of absorption characteristics of AG337, a novel thymidylate synthase inhibitor, using a perfused rat intestinal model.
    Hu M; Roland K; Ge L; Chen J; Li Y; Tyle P; Roy S
    J Pharm Sci; 1998 Jul; 87(7):886-90. PubMed ID: 9649359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleobase- and p-glycoprotein-mediated transport of AG337 in a Caco-2 cell culture model.
    Hu M; Chen J
    Mol Pharm; 2004; 1(3):194-200. PubMed ID: 15981922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AG337, a novel lipophilic thymidylate synthase inhibitor: in vitro and in vivo preclinical studies.
    Webber S; Bartlett CA; Boritzki TJ; Hillard JA; Howland EF; Johnston AL; Kosa M; Margosiak SA; Morse CA; Shetty BV
    Cancer Chemother Pharmacol; 1996; 37(6):509-17. PubMed ID: 8612303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetic and pharmacodynamic studies with the nonclassical antifolate thymidylate synthase inhibitor 3, 4-dihydro-2-amino-6-methyl-4-oxo-5-(4-pyridylthio)-quinazolone dihydrochloride (AG337) given by 24-hour continuous intravenous infusion.
    Rafi I; Taylor GA; Calvete JA; Boddy AV; Balmanno K; Bailey N; Lind M; Calvert AH; Webber S; Jackson RC
    Clin Cancer Res; 1995 Nov; 1(11):1275-84. PubMed ID: 9815922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the effect of AG337, a novel lipophilic thymidylate synthase inhibitor, on human head and neck and human leukemia cell lines.
    McGuire JJ; Canestrari JG; Nagel GS
    Int J Oncol; 1999 Dec; 15(6):1245-50. PubMed ID: 10568835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situ.
    Varma MV; Panchagnula R
    J Pharm Sci; 2005 Dec; 94(12):2632-43. PubMed ID: 16258992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport characteristics of 9-nitrocamptothecin in the human intestinal cell line Caco-2 and everted gut sacs.
    Sha X; Fang X
    Int J Pharm; 2004 Mar; 272(1-2):161-71. PubMed ID: 15019079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intestinal absorption of berberine alone and in combinations by rats single pass intestinal perfusion in situ].
    Zhang Y; Zhu HX; Guo LW
    Yao Xue Xue Bao; 2012 Feb; 47(2):233-8. PubMed ID: 22512037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration- and region-dependent intestinal permeability of fluvastatin in the rat.
    Lindahl A; Sandström R; Ungell AL; Lennernäs H
    J Pharm Pharmacol; 1998 Jul; 50(7):737-44. PubMed ID: 9720622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-[11C]thymidine positron emission tomography as an indicator of thymidylate synthase inhibition in patients treated with AG337.
    Wells P; Aboagye E; Gunn RN; Osman S; Boddy AV; Taylor GA; Rafi I; Hughes AN; Calvert AH; Price PM; Newell DR
    J Natl Cancer Inst; 2003 May; 95(9):675-82. PubMed ID: 12734319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal permeability of forskolin by in situ single pass perfusion in rats.
    Liu ZJ; Jiang DB; Tian LL; Yin JJ; Huang JM; Weng WY
    Planta Med; 2012 May; 78(7):698-702. PubMed ID: 22411728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of concentrative nucleoside transporter 1 in intestinal absorption of trifluorothymidine, a novel antitumor nucleoside, in rats.
    Okayama T; Yoshisue K; Kuwata K; Komuro M; Ohta S; Nagayama S
    J Pharmacol Exp Ther; 2012 Feb; 340(2):457-62. PubMed ID: 22076553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption and intestinal metabolism of purine dideoxynucleosides and an adenosine deaminase-activated prodrug of 2',3'-dideoxyinosine in the mesenteric vein cannulated rat ileum.
    Singhal D; Ho NF; Anderson BD
    J Pharm Sci; 1998 May; 87(5):569-77. PubMed ID: 9572907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Difference absorption of l-tetrahydropalmatine and dl-tetrahydropalmatine in intestine of rats].
    Wu PS; Huang SD; Ye YJ; Sun SY; Jiang HD
    Yao Xue Xue Bao; 2007 May; 42(5):534-7. PubMed ID: 17703779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acids in the rat intestinal lumen regulate their own absorption from a distant intestinal site.
    Mourad FH; Barada KA; Khoury C; Hamdi T; Saadé NE; Nassar CF
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G292-8. PubMed ID: 19541927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral absorption of anti-acquired immune deficiency syndrome nucleoside analogues. 2. Carrier-mediated intestinal transport of stavudine in rat and rabbit preparations.
    Waclawski AP; Sinko PJ
    J Pharm Sci; 1996 May; 85(5):478-85. PubMed ID: 8742938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal absorption of gamma-tocotrienol is mediated by Niemann-Pick C1-like 1: in situ rat intestinal perfusion studies.
    Abuasal B; Sylvester PW; Kaddoumi A
    Drug Metab Dispos; 2010 Jun; 38(6):939-45. PubMed ID: 20207946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption and metabolism of purines by the small intestine of the chicken.
    Karasawa Y; Ishi-I T; Kubota T
    Comp Biochem Physiol A Comp Physiol; 1991; 99(1-2):235-40. PubMed ID: 1675952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal phosphate absorption is mediated by multiple transport systems in rats.
    Candeal E; Caldas YA; Guillén N; Levi M; Sorribas V
    Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G355-G366. PubMed ID: 28232455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prolonged omeprazole administration on segmental intestinal Mg
    Suksridechacin N; Kulwong P; Chamniansawat S; Thongon N
    World J Gastroenterol; 2020 Mar; 26(11):1142-1155. PubMed ID: 32231419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.